Curi RMB Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$537K Buy
6,295
+454
+8% +$40.5K 0.01% 584
2025
Q4
$462K Buy
5,841
+883
+18% +$69.2K 0.01% 636
2025
Q3
$396K Sell
4,958
-31
-0.6% -$2.64K 0.01% 553
2025
Q2
$453K Buy
+4,989
New +$455K 0.01% 528
2024
Q4
Sell
-1,959
Closed -$203K 522
2024
Q3
$203K Sell
1,959
-3,746
-66% -$382K ﹤0.01% 531
2024
Q2
$554K Buy
5,705
+850
+18% +$78.4K 0.01% 407
2024
Q1
$437K Sell
4,855
-59
-1% -$5K 0.01% 451
2023
Q4
$392K Sell
4,914
-16
-0.3% -$1.2K 0.01% 410
2023
Q3
$351K Buy
4,930
+13
+0.3% +$972 0.01% 412
2023
Q2
$379K Buy
4,917
+6
+0.1% +$464 0.01% 405
2023
Q1
$369K Sell
4,911
-826
-14% -$61.4K 0.01% 400
2022
Q4
$452K Buy
5,737
+39
+0.7% +$2.92K 0.02% 375
2022
Q3
$400K Buy
5,698
+3,201
+128% +$251K 0.01% 379
2022
Q2
$200K Buy
+2,497
New +$195K 0.01% 460
2022
Q1
Sell
-2,397
Closed -$205K 441
2021
Q4
$205K Buy
+2,397
New +$187K 0.01% 444
2019
Q2
Sell
-5,406
Closed -$371K 760
2019
Q1
$371K Buy
5,406
+181
+3% +$11.7K 0.01% 633
2018
Q4
$311K Sell
5,225
-4
-0.1% -$250 0.01% 733
2018
Q3
$350K Sell
5,229
-275
-5% -$18.3K 0.01% 694
2018
Q2
$357K Sell
5,504
-207
-4% -$13.5K 0.01% 685
2018
Q1
$409K Sell
5,711
-3,928
-41% -$283K 0.01% 666
2017
Q4
$727K Hold
9,639
0.02% 537
2017
Q3
$702K Buy
9,639
+494
+5% +$35.6K 0.02% 474
2017
Q2
$678K Buy
9,145
+298
+3% +$22.1K 0.02% 492
2017
Q1
$647K Buy
8,847
+1,510
+21% +$106K 0.03% 343
2016
Q4
$480K Buy
+7,337
New +$503K 0.03% 316

Other funds holding CL

Curi RMB Capital's CL Position: Q1 2026 in Review

Curi RMB Capital increased its Colgate-Palmolive (CL) stake by 7.8% in Q1 2026, buying an estimated $40.5K and bringing the position to 6,295 shares worth $537K. The position accounts for 0.01% of the portfolio, ranked #584.

Curi RMB Capital first reported a position in CL in Q4 2016 and has held it in 25 quarters since. The position peaked at $727K in Q4 2017. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Curi RMB Capital held 6,295 shares of Colgate-Palmolive worth $537K as of Q1 2026.
  • Curi RMB Capital bought 454 Colgate-Palmolive shares in Q1 2026, an estimated $40.5K.
  • Colgate-Palmolive made up 0.01% of Curi RMB Capital's portfolio in Q1 2026, its #584 holding.
  • Curi RMB Capital first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 25 quarters since.
  • Curi RMB Capital's Colgate-Palmolive position peaked at $727K in Q4 2017.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.